SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001447028-21-000042
Filing Date
2021-06-07
Accepted
2021-06-07 16:25:02
Documents
2
Period of Report
2021-06-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162309748590209.html 4  
1 FORM 4 wf-form4_162309748590209.xml 4 4069
2 POA - MEYERS poa-meyers.htm EX-24 3321
  Complete submission text file 0001447028-21-000042.txt   8927
Mailing Address GILEAD SCIENCES, INC. 333 LAKESIDE DRIVE FOSTER CITY CA 94404
Business Address
Meyers James R (Reporting) CIK: 0001387521 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-34949 | Film No.: 21999814

Mailing Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8
Business Address 100-8900 GLENLYON PARKWAY BURNABY A1 V5J 5J8 604-419-3200
Arbutus Biopharma Corp (Issuer) CIK: 0001447028 (see all company filings)

IRS No.: 980597776 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations